about
Targeted Therapy in Biliary Tract CancersMutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study.Adiposity across the adult life course and incidence of primary liver cancer: The NIH-AARP cohort.Oxidative stress balance is dysregulated and represents an additional target for treating cholangiocarcinoma.Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Obesity and cholangiocarcinoma
@ast
Obesity and cholangiocarcinoma
@en
type
label
Obesity and cholangiocarcinoma
@ast
Obesity and cholangiocarcinoma
@en
prefLabel
Obesity and cholangiocarcinoma
@ast
Obesity and cholangiocarcinoma
@en
P2860
P356
P1476
Obesity and cholangiocarcinoma
@en
P2093
Mansour A Parsi
P2860
P304
P356
10.3748/WJG.V19.I4.457
P407
P577
2013-01-01T00:00:00Z